WASHINGTON — Michelle McMurry-Heath doesn’t talk about biotech the way her peers do.
Where other executives and experts might bring up “access,” and “reimbursement,” McMurry-Heath talks about fairness and ethics.
Image: Michelle McMurry-Heath has been named the new CEO of BIO.
{iframe}https://www.statnews.com/2020/05/14/bio-lobbyist-ceo-michelle-mcmurray-heath/{/iframe}